Of particular relevance, rapamycin-mediated mTOR inhibition has been shown to restore neurovascular coupling and memory performance in AD mouse models by reversing both nitric oxide synthase-dependent and independent cerebrovascular deficits [96]. Here, MTOR is linked to Alzheimer disease.